About us
- Since its inception, OBD has focused on:-
- OBD is setting up regional diagnostic health-care service providers in South-East Asia, Australia, Europe and the Middle East, to commercialize its technology in different diagnostic and therapeutic areas.
- In the short term OBD is looking at specific diseases and drug targets where the technology would have the greatest effect including breast cancer, heart disease, liver cancer and melanoma.
- OBD holding company is registered in England and Wales and has a subsidiary in Singapore.
| » | developing and standardising its technology for a set of unique diagnostic applications |
| » | establishing collaborations and feasibility studies with leading academic research groups |
| » | filing of patents, and securing newly generated intellectual property and technical know-how |